A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
Sanjay Popat, Alessandra Curioni Fontecedro, Varvara Polydoropoulou et al. · Annals of Oncology · 2019
Cited by 55 works. doi:10.1093/annonc/mdz394.091
Authors
- Sanjay Popat
- Alessandra Curioni Fontecedro
- Varvara Polydoropoulou
- Riyaz N.H. Shah
- Mary E.R. O'Brien
- A. Pope
- P.M. Fisher
- James F. Spicer
- A. Roy
- DAVID M. GILLIGAN
- Oliver Pascal Gautschi
- Ernest Nadal
- Wolf-Dieter Janthur
- Rafael López Castro
- Rosario García Campelo
- Heidi Roschitzki‐Voser
- Barbara Ruepp
- Sylvie Rusakiewicz
- Solange Peters
- Rolf Arno Stahel